In Brief: Aequitron/CNS
This article was originally published in The Gray Sheet
Executive Summary
Aequitron/CNS: Complete deal under which Aequitron will acquire CNS' sleep diagnostic business. The acquisition involves the combination of a payment of cash and short-term debt totaling approximately $5.6 mil., for which Aequitron receives "all rights to CNS' sleep diagnostic products, all applicable patents and a product currently under development." In addition, Aequitron obtains non-exclusive distribution rights for CNS' Breathe Right nasal strips "in professional health care markets." The sleep business accounted for about $7 mil. in CNS revenues during the company's last fiscal year...